Genius Sports Limited (GENI)
NYSE: GENI · IEX Real-Time Price · USD
5.87
+0.17 (2.98%)
At close: Jul 19, 2024, 4:00 PM
5.88
+0.01 (0.17%)
After-hours: Jul 20, 2024, 12:58 PM EDT

Genius Sports Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Revenue
435.47412.98341.03262.74149.74114.62
Revenue Growth (YoY)
23.59%21.10%29.80%75.46%30.64%-
Cost of Revenue
363.19343.97338.17476.17114.0789.31
Gross Profit
72.2869.012.86-213.4335.6725.31
Selling, General & Admin
119.13114.6154.17320.4644.847.2
Research & Development
26.4226.0729.8926.5111.2413.29
Other Operating Expenses
2.132.491.6712.890.671.01
Operating Expenses
147.69143.16185.74359.8656.7161.5
Operating Income
-75.41-74.16-182.87-573.29-21.04-36.19
Interest Expense / Income
-1.54-1.951.493.337.876.84
Other Expense / Income
6.247.99-4.4427.83-0.382.54
Pretax Income
-80.12-80.19-179.92-604.45-28.54-45.57
Income Tax
5.795.341.71-11.71.81-5.37
Net Income
-85.91-85.53-181.64-592.75-30.35-40.21
Preferred Dividends
00011.3331.8728.32
Net Income Common
-85.91-85.53-181.64-604.08-62.22-68.53
Shares Outstanding (Basic)
2292262131597068
Shares Outstanding (Diluted)
2292262131597068
Shares Change
3.44%5.85%33.88%127.57%2.38%-
EPS (Basic)
-0.37-0.38-0.85-3.79-0.89-1.00
EPS (Diluted)
-0.37-0.38-0.85-3.79-0.89-1.00
Free Cash Flow
-30.68-32.83-50.04-96.47-0.26-21.38
Free Cash Flow Per Share
-0.13-0.14-0.23-0.60-0.00-0.31
Gross Margin
16.60%16.71%0.84%-81.24%23.82%22.08%
Operating Margin
-17.32%-17.96%-53.62%-218.20%-14.05%-31.57%
Profit Margin
-19.73%-20.71%-53.26%-229.92%-41.55%-59.79%
Free Cash Flow Margin
-7.04%-7.95%-14.67%-36.72%-0.17%-18.65%
EBITDA
3.55-0.91-103.88-541.7714.38-10.76
EBITDA Margin
0.81%-0.22%-30.46%-206.20%9.60%-9.39%
Depreciation & Amortization
85.281.2474.5659.3535.0427.97
EBIT
-81.65-82.15-178.44-601.12-20.66-38.73
EBIT Margin
-18.75%-19.89%-52.32%-228.79%-13.80%-33.79%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).